Navigation Links
Blood cell researcher wins science academy's 2013 Gottschalk Medal
Date:1/15/2013

Walter and Eliza Hall Institute researcher Dr Benjamin Kile has been awarded the Australian Academy of Science's 2013 Gottschalk Medal for a series of major discoveries that have shed new light on blood cell formation and function.

The Gottschalk Medal, named in honour of biochemist Dr Alfred Gottschalk, recognises outstanding research in the medical sciences by researchers less than 40 years of age.

Dr Kile, a laboratory head in the institute's Cancer and Haematology division, said he was honoured to be awarded the Gottschalk Medal. "I love what I do, and it has been a privilege to be able to pursue a career in medical research in Australia," Dr Kile said. "This award is recognition for work that has involved literally dozens of colleagues and collaborators, here at the Walter and Eliza Hall Institute, nationally and internationally".

Dr Kile's work has centred on understanding the genes that are essential for the formation and function of blood cells and blood stem cells.

One of Dr Kile's best-known discoveries was that platelets, tiny cells essential for blood clotting, are born with a short, predetermined lifespan and when their biological clock runs out, they are programmed to commit suicide. This finding solved a 100-year-old mystery about platelet biology and has implications for blood transfusions and cancer treatment.

"Our research team showed platelets have an internal programmed cell death pathway that tells them when to die, rather than dying as a result of external factors," Dr Kile said. "This raises the prospect of extending the life span of blood bank platelets by inhibiting the cell death pathway; increasing the availability of this life-saving product for cancer patients and others in danger of serious bleeding," Dr Kile said. "It also has implications for understanding conditions where platelets cause unwanted blood clots, such as heart disease and stroke, which are two of the biggest killers in Australia today."

In 2008 Dr Kile and his colleagues also made the discovery that a gene called ERG, which is involved in prostate cancer and leukaemia, is a master regulator of blood stem cell function. Identifying the targets of ERG may ultimately lead to new cancer therapies.

"Everybody knew the Erg gene was highly oncogenic (cancer-causing) it is one of the most commonly rearranged genes in human cancer but we didn't know what its day job was," Dr Kile said. "Our research showed that Erg is essential for maintaining and regulating blood stem cells, which underpin the body's blood and immune systems. This immediately suggested an explanation for Erg's profound oncogenicity; cancers acquire a lot of characteristics of stem cells, so the fact it is switched on in tumours suddenly made sense."

Institute director Professor Doug Hilton said Dr Kile's discoveries, while having basic biological significance, have also directly informed clinical practice, and have the potential to lead to new therapeutics.

"Ben has shown a willingness to pursue the translational implications of his work to a remarkable degree," Professor Hilton said. "He has already cemented his international standing as one of the brightest young stars of blood cell research, and his career trajectory remains resolutely upwards."


'/>"/>
Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Related medicine news :

1. Infection Might Raise Blood Clot Risk for Older Adults: Study
2. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
3. Common Blood Pressure Drug Safe for Heart Failure: Study
4. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
5. High Blood Pressure May Be Especially Lethal for Blacks
6. Changes in gene expression may help explain high blood pressure in pregnancy
7. Researchers Develop Blood Test for Depression
8. Naturopathic care can improve blood sugar, mood in diabetes
9. Diabetes Groups Issue New Guidelines on Blood Sugar
10. Exercise May Help Patients With High Blood Pressure Live Longer
11. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood cell researcher wins science academy's 2013 Gottschalk Medal
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
(Date:10/2/2017)... Oct. 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Software and Consulting, LLC , and named its founder ... based in Tennessee , will operate ... expands EnvoyHealth,s service offerings for health care partners to ... "In an interoperable world, technology ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
Breaking Medicine Technology: